StonvexLoading…
StonvexStonvexStonvexCore line items from CCK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.26B | $12.37B | $9.24B | $6.04B |
Operating Income | $365.00M | $1.55B | $1.18B | $756.00M |
Net Income | $175.00M | $738.00M | $588.00M | $374.00M |
EPS (Diluted) | $1.56 | $6.38 | $5.06 | $3.21 |
Total Assets | $14.30B | $14.27B | $14.55B | $14.48B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $584.00M | $764.00M | $1.17B | $936.00M |
Free Cash Flow OCF − CapEx | $-141.00M | $1.12B | $862.00M | $374.00M |
Shares Outstanding | 112.50M | 113.42M | 116.20M | 116.50M |